[From histology via genetic signature to an improved treatment of breast cancer patients]

Rev Med Suisse. 2007 Oct 24;3(130):2382-4, 2386-8.
[Article in French]


Today, breast cancer prognosis and (neo-) adjuvant treatment selection are based on clinical as well as on histological and immunohistochemical data. Will genetic expression profiles have a better predictive value? Ongoing studies will provide the answer.

Publication types

  • English Abstract

MeSH terms

  • Breast Neoplasms / genetics
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy*
  • Female
  • Humans
  • Risk Assessment